Orexigen Therapeutic (OREX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OREX | AMGN | BMY | GILD | VRTX |
| Company | Orexigen Therapeutic | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.25 | 263.11 | 57.25 | 92.62 | 391.87 |
| High | 0.32 | 264.80 | 57.64 | 93.22 | 402.69 |
| Low | 0.22 | 260.87 | 56.80 | 91.79 | 390.92 |
| Last | 0.22 | 263.20 | 57.38 | 93.03 | 401.34 |
| Change | -0.12 | -0.18 | +0.05 | +0.46 | +4.07 |
| % Change | -34.41% | -0.07% | +0.09% | +0.50% | +1.02% |
| Volume | 3,735,400 | 1,372,362 | 3,958,427 | 2,110,358 | 1,133,064 |
| 20-Day Average Volume | 2,308,280 | 5,073,903 | 11,627,785 | 7,463,742 | 1,810,427 |
| Previous Close | 0.34 | 263.38 | 57.33 | 92.57 | 397.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.47 | 273.42 | 57.91 | 92.11 | 454.54 |
| 20-Day Raw Stochastic | 4.24% | 20.98% | 42.64% | 71.45% | 25.09% |
| 20-Day Relative Strength | 32.36% | 31.85% | 52.97% | 56.25% | 31.63% |
| Weighted Alpha | -72.99 | -15.47 | +19.60 | +24.48 | -9.62 |
| Today's Opinion | N/A | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Previous Opinion | N/A | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Last Month's Opinion | N/A | 40% Sell | 100% Buy | 80% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +17.37% since 03/27/18 | -1.49% since 12/16/24 | +2.82% since 12/16/24 | +1.12% since 12/16/24 | -13.99% since 12/16/24 |
| Low | 0.17 on 03/28/18 | 253.30 on 12/19/24 | 56.05 on 12/17/24 | 90.27 on 12/19/24 | 377.85 on 12/19/24 |
| High | 0.39 on 04/02/18 | 270.26 on 12/17/24 | 58.54 on 12/18/24 | 93.59 on 12/17/24 | 474.18 on 12/17/24 |
| 1-Month | |||||
| %Chg | -81.57% since 03/02/18 | -10.86% since 11/22/24 | -2.42% since 11/22/24 | +3.20% since 11/22/24 | -10.73% since 11/22/24 |
| Low | 0.17 on 03/27/18 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 | 377.85 on 12/19/24 |
| High | 1.42 on 03/09/18 | 297.32 on 11/25/24 | 60.68 on 11/25/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | -82.02% since 01/03/18 | -21.77% since 09/23/24 | +14.87% since 09/23/24 | +10.82% since 09/23/24 | -12.48% since 09/23/24 |
| Low | 0.17 on 03/27/18 | 253.30 on 12/19/24 | 49.11 on 09/25/24 | 81.83 on 09/26/24 | 377.85 on 12/19/24 |
| High | 1.60 on 02/22/18 | 335.41 on 09/24/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | -89.17% since 10/03/17 | -14.81% since 06/21/24 | +37.00% since 06/21/24 | +31.71% since 06/21/24 | -14.11% since 06/21/24 |
| Low | 0.17 on 03/27/18 | 253.30 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 377.85 on 12/19/24 |
| High | 2.32 on 10/13/17 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,212 | 141,575,456 | 116,275,392 | 115,366,840 | 102,308,544 |
| Shares Outstanding, K | 18,890 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 33,710,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -24,520,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 18,900,000 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -20,830,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | 2.46 | 0.55 | 0.45 | 0.18 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.35 on 11/13/17 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 05/08/18 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.70 | 49.00 | 20.90 | 0.00 |